Browsing Tag: Cancer Risk with Biologic Therapy

Lymphoma Risk Remains Elevated

A complication of rheumatoid arthritis that doesn’t appear to be decreasing… next

Rheumatoid Arthritis:   Lymphoma Risk Remains Elevated Despite Changing Treatment

Reported in Unavadis, a large study of Swedish health registry data indicates that lymphoma risk remains elevated among patients with rheumatoid arthritis (RA), despite evolution of treatment. Treatment advances for RA do not appear to have affected lymphoma risk. Records from 12,656 patients with RA from the Swedish Rheumatology Register linked to Swedish Cancer Register were compared with control patients for lymphoma incidence over time.

Comment: Disturbing since I would expect our newer treatments to decrease lymphoma risk.

Biologics don’t increase recurrence of cancer in Rheumatoid Arthritis

Do biologic drugs increase the risk of cancer recurrence in RA patients? Find out the answer next…

Biologics don’t increase recurrence of cancer in RA

Sara Freeman writing in Rheumatology News reported that the risk of cancer recurrence in patients with rheumatoid arthritis was not increased with the use of biologic therapy according to a recent British study.  Investigators from the Arthritis Research UK Epidemiology Unit at the University of Manchester studied 425 patients with prior cancer who were treated with biologics. Not only was the rate of recurrence not increased but there was an apparent decrease of 50% when compared with patients treated with traditional disease modifying anti-rheumatic drugs only.

Comment:  Well there it is.  I think that’s comforting news.

Search the Vlog